Filing metadata

Accession number
0001127602-19-026289
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Aug 09, 2019
Reporting period
Aug 07, 2019
Description
Insider transaction

Explore SEC Filings Hub